D4064A

· Genentech, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for D4064A, covering 2008-11-07 to 2008-11-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of D4064A Administered to Patients With Recurrent or Persistent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]

See pricing